Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction
NCT01593787Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sacubitril + valsartan in hypertension (HTN), sponsored by Novartis. Started May 2012; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01593787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01593787.